久光製薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2018/10/09 | 8,440 | 8,470 | 7,890 | 7,920 | -770 | -8.9% | 291,100 |
2018/10/05 | 8,660 | 8,780 | 8,630 | 8,690 | +30 | +0.3% | 136,900 |
2018/10/04 | 9,100 | 9,100 | 8,630 | 8,660 | -380 | -4.2% | 191,600 |
2018/10/03 | 9,140 | 9,260 | 9,020 | 9,040 | -20 | -0.2% | 173,300 |
2018/10/02 | 8,760 | 9,070 | 8,730 | 9,060 | +410 | +4.7% | 204,800 |
2018/10/01 | 8,640 | 8,710 | 8,520 | 8,650 | -60 | -0.7% | 129,100 |
2018/09/28 | 8,740 | 8,830 | 8,670 | 8,710 | +10 | +0.1% | 143,600 |
2018/09/27 | 8,910 | 8,980 | 8,690 | 8,700 | -210 | -2.4% | 130,700 |
2018/09/26 | 8,790 | 8,920 | 8,750 | 8,910 | +170 | +1.9% | 165,100 |
2018/09/25 | 8,710 | 8,790 | 8,600 | 8,740 | +90 | +1% | 181,200 |
2018/09/21 | 8,610 | 8,680 | 8,510 | 8,650 | +70 | +0.8% | 213,600 |
2018/09/20 | 8,640 | 8,650 | 8,520 | 8,580 | -60 | -0.7% | 104,100 |
2018/09/19 | 8,510 | 8,690 | 8,400 | 8,640 | +180 | +2.1% | 166,300 |
2018/09/18 | 8,270 | 8,480 | 8,220 | 8,460 | +250 | +3% | 129,100 |
2018/09/14 | 8,140 | 8,220 | 8,120 | 8,210 | +140 | +1.7% | 159,200 |
2018/09/13 | 8,050 | 8,250 | 8,010 | 8,070 | ±0 | ±0% | 145,000 |
2018/09/12 | 8,100 | 8,120 | 8,000 | 8,070 | -90 | -1.1% | 125,500 |
2018/09/11 | 7,960 | 8,180 | 7,960 | 8,160 | +240 | +3% | 130,500 |
2018/09/10 | 7,870 | 8,010 | 7,860 | 7,920 | +60 | +0.8% | 120,300 |
2018/09/07 | 7,700 | 7,890 | 7,700 | 7,860 | +60 | +0.8% | 131,600 |
2018/09/06 | 7,960 | 7,960 | 7,770 | 7,800 | -250 | -3.1% | 131,900 |
2018/09/05 | 8,100 | 8,130 | 8,020 | 8,050 | -40 | -0.5% | 117,900 |
2018/09/04 | 8,010 | 8,130 | 7,930 | 8,090 | +70 | +0.9% | 101,600 |
2018/09/03 | 8,090 | 8,090 | 8,000 | 8,020 | -100 | -1.2% | 73,000 |
2018/08/31 | 8,050 | 8,180 | 8,040 | 8,120 | +10 | +0.1% | 140,200 |
2018/08/30 | 8,140 | 8,220 | 8,100 | 8,110 | -20 | -0.2% | 116,200 |
2018/08/29 | 8,100 | 8,180 | 8,060 | 8,130 | +70 | +0.9% | 91,500 |
2018/08/28 | 8,310 | 8,310 | 8,030 | 8,060 | -250 | -3% | 133,000 |
2018/08/27 | 8,310 | 8,360 | 8,270 | 8,310 | +30 | +0.4% | 77,400 |
2018/08/24 | 8,250 | 8,290 | 8,230 | 8,280 | +70 | +0.9% | 59,200 |
2018/08/23 | 8,260 | 8,340 | 8,200 | 8,210 | +80 | +1% | 134,500 |
2018/08/22 | 8,010 | 8,180 | 8,000 | 8,130 | +120 | +1.5% | 126,700 |
2018/08/21 | 7,900 | 8,030 | 7,870 | 8,010 | +80 | +1% | 79,400 |
2018/08/20 | 7,950 | 8,010 | 7,900 | 7,930 | -20 | -0.3% | 85,100 |
2018/08/17 | 7,910 | 8,070 | 7,910 | 7,950 | +60 | +0.8% | 69,900 |
2018/08/16 | 7,980 | 7,980 | 7,820 | 7,890 | -120 | -1.5% | 164,700 |
2018/08/15 | 7,950 | 8,060 | 7,930 | 8,010 | -10 | -0.1% | 80,300 |
2018/08/14 | 7,910 | 8,040 | 7,880 | 8,020 | +100 | +1.3% | 93,800 |
2018/08/13 | 7,950 | 8,080 | 7,910 | 7,920 | -80 | -1% | 119,300 |
2018/08/10 | 8,040 | 8,060 | 7,940 | 8,000 | ±0 | ±0% | 138,600 |
2018/08/09 | 8,080 | 8,110 | 7,970 | 8,000 | -80 | -1% | 81,000 |
2018/08/08 | 8,170 | 8,190 | 8,060 | 8,080 | -130 | -1.6% | 130,000 |
2018/08/07 | 8,130 | 8,230 | 8,090 | 8,210 | +50 | +0.6% | 89,800 |
2018/08/06 | 8,010 | 8,190 | 7,990 | 8,160 | +140 | +1.7% | 153,100 |
2018/08/03 | 8,060 | 8,080 | 7,920 | 8,020 | -90 | -1.1% | 156,100 |
2018/08/02 | 8,300 | 8,300 | 8,100 | 8,110 | -230 | -2.8% | 149,100 |
2018/08/01 | 8,220 | 8,380 | 8,180 | 8,340 | +180 | +2.2% | 205,300 |
2018/07/31 | 8,080 | 8,200 | 8,000 | 8,160 | +30 | +0.4% | 225,900 |
2018/07/30 | 8,260 | 8,260 | 8,110 | 8,130 | -190 | -2.3% | 144,000 |
2018/07/27 | 8,270 | 8,330 | 8,160 | 8,320 | +100 | +1.2% | 125,100 |
1601~
1650
件表示中 / 3692件
類似銘柄と比較する
現在ご覧いただいている「久光薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
久光薬 | 443,700円 | +5.8% | +1.2% | 2.70% | 14.72倍 | 1.17倍 |
|
貼る鎮痛消炎剤首位。医療用シェア5割。大衆薬「サロンパス」で有名。米国、中国など海外強化 |
ロート | 241,800円 | +18.2% | +4.2% | 1.49% | 16.97倍 | 2.16倍 |
|
一般用医薬品の目薬で世界首位。「肌研」が急成長しスキンケアが柱に。アジアなど海外積極進出 |
参天薬 | 147,400円 | 0.0% | +50.6% | 2.44% | 15.48倍 | 1.74倍 |
|
緑内障、加齢黄斑変性、ドライアイ治療薬など眼科用医薬品首位。一般用目薬「サンテ」が有名 |
住友ファーマ | 94,100円 | +26.8% | - | 0.00% | 15.84倍 | 3.27倍 |
|
医薬品準大手、住友化学傘下。買収で米国へ展開。研究開発は精神神経、がん、再生細胞に重点 |
ツムラ | 430,100円 | +20.9% | +87.3% | 3.16% | 9.61倍 | 1.11倍 |
|
医療用漢方薬で国内シェア8割超。高齢者、がん支持療法、女性関連の3領域を重点に市場深耕 |
市場注目の銘柄
チャート関連のコラム